BE study design issue [Design Issues]

posted by Dr_Dan  – 2019-12-18 15:04  – Posting: # 20992
Views: 280

Hi John
if the recommended dosage regimen of the IR as per product monograph IR is to be given every 4 hrs then this means that higher doses have either a safety issue or the dose/effect relationship is in disfavor of higher doses. In this case AUC alone does not matter. Consequently, a regulatory body will reject the study
Hope this helps
KR
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

Activity
 Admin contact
20,237 posts in 4,258 threads, 1,397 registered users;
online 12 (1 registered, 11 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 10:40 CET

Science may set limits to knowledge,
but should not set limits to imagination.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5